Tela Bio Inc Expected To Post A Loss Of 50 Cents A Share: Earnings Preview

TELA Bio

08/05/2024 01:09

* TELA Bio Inc  TELA.OQ   TELA.O  is expected to show a rise
in
quarterly revenue when it reports  results on May 9 for the
period ending March 31 2024
    * The Malvern Pennsylvania-based  company is expected to
report a
37.0% increase in revenue to $16.319 million from $11.91 million
a year ago, according to the mean estimate from 5 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for TELA Bio Inc is for a
loss
of 50 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for TELA Bio
Inc is
$14.00​, above​ its last closing price of $4.92. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.42       -0.43      -0.53     Missed  -21.9
 Sep. 30 2023  -0.49       -0.49      -0.45     Beat    8.5
 Jun. 30 2023  -0.53       -0.53      -0.46     Beat    13.7​
 Mar. 31 2023  -0.56       -0.56      -0.63     Missed  -12.7
 ​​Dec.        -0.51       -0.55      -0.52     Beat    4.8
 31 2022                                                
 Sep. 30 2022  -0.63       -0.63      -0.64     Missed  -2.3​
 Jun. 30 2022  -0.65       -0.62      -0.79     Missed  -27.8
 Mar. 31 2022  -0.56       -0.56      -0.75     Missed  -34.5
 This summary was machine generated May 8 at 00:09 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)